Literature DB >> 33536949

Aging as a Context for the Role of Inflammation in Depressive Symptoms.

Kelci Straka1, Mai-Lan Tran1, Summer Millwood1, James Swanson1, Kate Ryan Kuhlman1,2,3.   

Abstract

Inflammation has been implicated in the pathogenesis and maintenance of depressive symptoms. The role of inflammation in depressive symptomatology may be complex, varying within endophenotypes and across the lifespan. Aging is associated with myriad changes in the structure and function of the brain. Yet, little attention has been given to the role of inflammation in depressive symptoms within a lifespan developmental framework. In this study, we examined whether the association between inflammation and depressive symptom domains varied by age. Participants were a community sample of individuals (N = 2,077, Range = 30-84) who participated in the Biomarker projects of the MIDUS2, MIDUS Refresher, or the MIDJA study. Inflammation was indexed by two inflammatory markers consistently implicated in depressed individuals, interleukin 6 (IL-6) and C-reactive protein (CRP), measured in blood. Depressive symptom domains, including depressed affect, anhedonia, somatic complaints, and interpersonal problems, were reported via the Center for Epidemiologic Studies-Depression Scale (CES-D). Inflammatory markers were associated with more somatic complaints, more interpersonal problems, and less anhedonia. Age moderated the relationship between inflammatory markers and two depressive symptom subscales. Specifically, the positive association between inflammation and somatic complaints and the negative association between inflammation and anhedonia increased with age. These observations offer preliminary evidence from a large community sample that aging may be an important context for the role of inflammatory signaling in different aspects of psychological and behavioral well-being.
Copyright © 2021 Straka, Tran, Millwood, Swanson and Kuhlman.

Entities:  

Keywords:  aging; anhedonia; depression; immune system; inflammation; lifespan; somatic complaints

Year:  2021        PMID: 33536949      PMCID: PMC7848015          DOI: 10.3389/fpsyt.2020.605347

Source DB:  PubMed          Journal:  Front Psychiatry        ISSN: 1664-0640            Impact factor:   4.157


  95 in total

1.  Longitudinal relationship of low leisure satisfaction but not depressive symptoms with systemic low-grade inflammation in dementia caregivers.

Authors:  Roland von Känel; Brent T Mausbach; Paul J Mills; Joel E Dimsdale; Thomas L Patterson; Sonia Ancoli-Israel; Michael G Ziegler; Matthew Allison; Elizabeth A Chattillion; Igor Grant
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2013-05-06       Impact factor: 4.077

Review 2.  From stress to inflammation and major depressive disorder: a social signal transduction theory of depression.

Authors:  George M Slavich; Michael R Irwin
Journal:  Psychol Bull       Date:  2014-01-13       Impact factor: 17.737

3.  Genetic theorizing and schizophrenia.

Authors:  I I Gottesman; J Shields
Journal:  Br J Psychiatry       Date:  1973-01       Impact factor: 9.319

4.  Clinical implications of "subthreshold" depressive symptoms.

Authors:  P M Lewinsohn; A Solomon; J R Seeley; A Zeiss
Journal:  J Abnorm Psychol       Date:  2000-05

5.  Longitudinal analysis of nortriptyline side effects in elderly depressed patients.

Authors:  M D Miller; B G Pollock; A H Rifai; C F Paradis; J M Perel; C George; J A Stack; C F Reynolds
Journal:  J Geriatr Psychiatry Neurol       Date:  1991 Oct-Dec       Impact factor: 2.680

6.  Heritability of individual depressive symptoms.

Authors:  Kerry L Jang; W John Livesley; Steven Taylor; Murray B Stein; Erin C Moon
Journal:  J Affect Disord       Date:  2004-06       Impact factor: 4.839

7.  Neuroendocrine and inflammatory factors associated with positive affect in healthy men and women: the Whitehall II study.

Authors:  Andrew Steptoe; Katie O'Donnell; Ellena Badrick; Meena Kumari; Michael Marmot
Journal:  Am J Epidemiol       Date:  2007-10-04       Impact factor: 4.897

Review 8.  Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.

Authors:  Andrew H Miller; Ebrahim Haroon; Charles L Raison; Jennifer C Felger
Journal:  Depress Anxiety       Date:  2013-03-06       Impact factor: 6.505

Review 9.  Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.

Authors:  Claudio Franceschi; Judith Campisi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-06       Impact factor: 6.053

10.  Persistent depressive symptoms, HPA-axis hyperactivity, and inflammation: the role of cognitive-affective and somatic symptoms.

Authors:  Eleonora Iob; Clemens Kirschbaum; Andrew Steptoe
Journal:  Mol Psychiatry       Date:  2019-08-21       Impact factor: 15.992

View more
  1 in total

Review 1.  Inflammaging and Cannabinoids.

Authors:  Babak Baban; Hesam Khodadadi; Évila Lopes Salles; Vincenzo Costigliola; John C Morgan; David C Hess; Kumar Vaibhav; Krishnan M Dhandapani; Jack C Yu
Journal:  Ageing Res Rev       Date:  2021-10-15       Impact factor: 10.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.